Targeting virulence: can we make evolution-proof drugs?

@article{Allen2014TargetingVC,
  title={Targeting virulence: can we make evolution-proof drugs?},
  author={R. C. Allen and R. Popat and S. Diggle and S. Brown},
  journal={Nature Reviews Microbiology},
  year={2014},
  volume={12},
  pages={300-308}
}
  • R. C. Allen, R. Popat, +1 author S. Brown
  • Published 2014
  • Biology, Medicine
  • Nature Reviews Microbiology
  • Antivirulence drugs are a new type of therapeutic drug that target virulence factors, potentially revitalising the drug-development pipeline with new targets. As antivirulence drugs disarm the pathogen, rather than kill or halt pathogen growth, it has been hypothesized that they will generate much weaker selection for resistance than traditional antibiotics. However, recent studies have shown that mechanisms of resistance to antivirulence drugs exist, seemingly damaging the 'evolution-proof… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Probing the evolutionary robustness of two repurposed drugs targeting iron uptake in Pseudomonas aeruginosa
    • 1
    • Highly Influenced
    • Open Access
    Small Molecules That Sabotage Bacterial Virulence.
    • 57
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 107 REFERENCES